Atomoxetine Chloro Impurity CAS 114446-47-8
| CAS No. | 114446-47-8 |
| Molecular Formula | C16H17ClO |
| Molecular Weight | 260.76 g/mol |
| Category | Pharmaceutical Standards / API Standards |
| Availability | In Stock |
Chemical Structure
Description
Under current pharmacopoeial and regulatory frameworks, quality-control requirements for this class of reference material explicitly involve the control of targets including Atomoxetine Chloro Impurity.
Atomoxetine Chloro Impurity (CAS 114446-47-8), molecular formula C16H17ClO and molecular weight 260.76 g/mol, is a CATO reference standard with documented purity and traceability.
Atomoxetine Chloro Impurity (C16H17ClO) contains a hydroxyl group, an ether linkage, chlorine substitution, a polycyclic aromatic system. Halogen substitution raises its density and boiling point, its high carbon-to-hydrogen ratio confers good lipid solubility; these physicochemical properties determine the optimal preparation and storage of its standard solutions. The aromatic system may exhibit native fluorescence, enabling detection with a fluorescence detector (FLD).
Recommended for analytical method development and validation; each product is supplied with a full Certificate of Analysis (COA) ensuring ISO 17034 metrological traceability.
The assigned purity is verified by mass-balance and quantitative NMR (qNMR) approaches, with the expanded uncertainty reported at a 95% confidence level (k=2). Batch homogeneity and stability are independently assessed for every lot.
Physical & Chemical Properties
| Molecular Formula | C16H17ClO |
| Molecular Weight | 260.76 g/mol |
| Purity | 97%+ |
| Storage | Store at 2-8°C, protect from light, keep tightly closed to prevent evaporation |
| Solubility (reference) | Soluble in chloroform, dichloromethane, ethyl acetate, DMSO |
| Stability | May oxidize slowly on prolonged air exposure; Light-sensitive; avoid direct strong light |
| Degree of Unsaturation (DBE) | 8.0 |
| UV Absorption | UV-absorbing |
| Structural Features | Aromatic ring present |
| CAS Registry Year (est.) | 1989 |
| Halogen Content | Cl-containing |
Related Atomoxetine Standards
- Atomoxetine 4-Hydroxy 2-Methyl Impurity (CAS 540729-12-2)
- rac-Atomoxetine EP Impurity C (CAS 56161-78-5)
- Atomoxetine Impurity 19 (CAS CATO-C4X-155019)
- Atomoxetine impurity 34 (CAS 908846-37-7)
- Atomoxetine impurity 35 (CAS 1638508-19-6)
- Atomoxetine EP Impurity C (CAS 1010818-96-8)
- Atomoxetine EP impurity B (CAS 105314-53-2)
- Atomoxetine Impurity N15 (CAS 1643684-02-9)
Recommended Standards
- 7-Chloro-8-methyl-4-(piperidin-1-yl)quinoline (CAS 1072944-74-1)
- (S)-3-Chloro-1-phenyl-1-[2-methyl-phenoxyl]propane (CAS 114446-50-3)
- N1-benzyl-6-chloro-N1-ethylbenzene-1,2-diamine (CAS 1039315-23-5)
- 3-Chloro-1-(4-((tetrahydrofuran-2-yl)methyl)piperazin-1-yl)propan-1-one (CAS 1178838-61-3)
- tert-Butyl (2R,3R)-2,3-diphenylpiperazine-1-carboxylate (CAS 1241681-30-0)
- 1,2-Dimethyl-1H-indole-3-carboxaldehyde (CAS 38292-40-9)
- 6-(4-Fluorophenyl)-[1,3]dioxolo[4,5-g]quinazolin-8(5H)-one (CAS 656833-95-3)
- Isobutyric Acid (CAS 79-31-2)
- 3-(Thiazol-5-yl)propanamide (CAS 1101219-69-5)
- N-[(2,5-Dichlorophenyl)methyl]piperidine-2-carboxamide (CAS 190509-38-7)
- Benfotiamine Impurity 3 (CAS CATO-C4X-28163)
- 2-(2-Methoxyphenyl)pyridin-4-amine (CAS 876601-38-6)
- 2,4-Dimethyl-5-(3-(trifluoromethyl)phenyl)pyrimidine (CAS 1261628-72-1)
- Gastric Inhibitory Polypeptide (3-42) (human) trifluoroacetate salt (CAS 1802086-25-4)
Why CATO?
- ISO 17034 accredited reference material producer (CNAS + ANAB dual accreditation)
- 130,000+ catalog items in stock, COA supplied with every batch
- Worldwide shipping with full export documentation (HS code guidance available)
- Technical support: +86 18665070610 / Nicole.chen@cato-chem.com